semaglutide patent expiration China's weight-loss drug makers take on global giants as Novo Nordisk expires When do the patents on

GLP-1 medications can stimulate it

Similar Efficacy and Gastrointestinal Tolerability Versus Exposure for Oral and Subcutaneous Semaglutide, in: The 55th Annual Meeting of the European Association for the Study of Diabetes (EASD Virtual Meeting), Abstract #777

Important Caveats: This observation is anecdotal, not registry-derived It is not a substitute for controlled epidemiology It provides real-world context consistent with MTC rarity and absence of compelling causal signals in highest-quality human evidence Clinical Significance: In a practice seeing more thyroid cancer than anywhere globally, we are not observing an MTC wave in GLP-1 users

Meet Alice & Brian - Case Studies of Specialty Drug Costs A closer look at the data and the stories of patients paints a more complicated picture